Streptomycin
Information about Streptomycin[edit]
streptomycin is a broad spectrum aminoglycoside antibiotic typically used for treatment of active tuberculosis, always in combination with other antituberculosis agents.
Liver safety of Streptomycin[edit]
Streptomycin is usually used in combination with agents that are known to be hepatotoxic and the role of streptomycin in liver injury has been difficult to assess, but most information suggests that streptomycin is not hepatotoxic.
Mechanism of action of Streptomycin[edit]
Streptomycin (strep" toe mye' sin), an aminoglycoside antibiotic, must be given by parenteral injection and is now considered a second line antituberculosis agent, used largely when toxicity has limited use of first line agents. Like other aminoglycosides, streptomycin is thought to act by binding to bacterial ribosomes and inhibiting protein synthesis. Nevertheless, streptomycin is considered bacteriocidal as well as bacteriostatic.
FDA approval information for Streptomycin[edit]
Streptomycin was approved for use in the United States in 1956, but its use for most indications has been replaced by more modern aminoglycoside antibiotics. streptomycin is available in vials and as lyophilized powder for injection in multiple generic formulations.
Dosage and administration for Streptomycin[edit]
The typical adult dose is 15 mg/kg per day (1 gram daily) intramuscularly or intravenously, usually for the first 2 to 4 months of antituberculosis therapy only. The dose must be modified based upon renal function.
Side effects of Streptomycin[edit]
Common side effects are auditory and renal dysfunction.
List of aminoglycosides
